News

News stories

Professor Dame Pamela Shaw
Professor Dame Pamela Shaw

World-renowned MND researcher and clinician says making research easier to understand, and showing why it matters, is vital

One of the world’s leading scientists on motor neurone disease (MND) and other neurological diseases says making complex research more accessible and understandable is vital to show progress is being made at developing treatments for the conditions.
DNA strand

FDA approves trial to advance pioneering treatment for Hereditary Spastic Paraplegia (HSP)

The US Food and Drug Administation (FDA) has approved BlackfinBio Limited’s Phase 1/2 clinical trial for its novel adeno-associated virus (AAV) gene therapy targeting Hereditary Spastic Paraplegia (HSP) Type 47 (SPG47).
DNA strands

ΞΆΓάΘ¦ spinout takes major step towards advancing pioneering treatments for Hereditary Spastic Paraplegia (HSP)

BlackfinBio Limited is a spinout company from the University of ΞΆΓάΘ¦ set to pioneer novel therapies for rare genetic neurological diseases.

Image of motor neurones

Groundbreaking EXPERTS-ALS study for MND treatments

The EXPErimental medicine Route To Success in ALS (EXPERTS-ALS) project aims to rapidly screen potential drugs for evidence that they can slow down damage to the nervous system occurring in people with motor neuron disease
Neuron cells system - 3d rendered image of Neuron cell network on black background

University of ΞΆΓάΘ¦ spinout company Crucible Therapeutics raises Β£5 million to advance pioneering treatments for neurological diseases

University of ΞΆΓάΘ¦ spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured Β£5 million from Northern Gritstone.
Researchers in SITraN lab

PhD opportunity available with the Neuroscience Institute

We have a PhD opportunity available that can be in a number of research areas.

Dr Dan Blackburn from the University of ΞΆΓάΘ¦ introducing a study participant to the CognoSpeak system on a laptop

Dementia diagnosis could be sped up thanks to AI

A new AI tool that could help doctors assess the early signs of dementia and Alzheimer’s more quickly and efficiently, has been developed by researchers at the University of ΞΆΓάΘ¦.
Head up collar

ΞΆΓάΘ¦-developed HeadUp Collar wins global award for patient driven research

A cross-organisation collaboration led by ΞΆΓάΘ¦ has been awarded for the development of an innovative neck collar designed for people affected by MND; the first ever global award celebrating excellence in patient engagement.
DNA molecule illustration

BenevolentAI progresses BEN-34712 for the potential treatment of ALS into IND-enabling studies

Benevolent AI, working alongside University of ΞΆΓάΘ¦ researchers have announced the successful delivery of its pre-clincal candidate,Β BEN-34712, for the potential treatment ofΒ motor neurone disease.